Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 5868913, 11 pages
http://dx.doi.org/10.1155/2016/5868913
Research Article

Exercise Training Attenuates Upregulation of p47phox and p67phox in Hearts of Diabetic Rats

1Department of Cellular & Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
2Division of Cardiology, University of Nebraska Medical Center, Omaha, NE 68198, USA

Received 14 July 2015; Revised 24 September 2015; Accepted 21 December 2015

Academic Editor: José Luís García-Giménez

Copyright © 2016 Neeru M. Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Dandamudi, J. Slusser, D. W. Mahoney, M. M. Redfield, R. J. Rodeheffer, and H. H. Chen, “The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota,” Journal of Cardiac Failure, vol. 20, no. 5, pp. 304–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. B. Devereux, M. J. Roman, M. Paranicas et al., “Impact of diabetes on cardiac structure and function: the Strong Heart study,” Circulation, vol. 101, no. 19, pp. 2271–2276, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Ilercil, R. B. Devereux, M. J. Roman et al., “Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart study,” American Heart Journal, vol. 141, no. 6, pp. 992–998, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Rubler, J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman, “New type of cardiomyopathy associated with diabetic glomerulosclerosis,” The American Journal of Cardiology, vol. 30, no. 6, pp. 595–602, 1972. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy revisited,” Circulation, vol. 115, no. 25, pp. 3213–3223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Aneja, W. H. W. Tang, S. Bansilal, M. J. Garcia, and M. E. Farkouh, “Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options,” American Journal of Medicine, vol. 121, no. 9, pp. 748–757, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Falcão-Pires and A. F. Leite-Moreira, “Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment,” Heart Failure Reviews, vol. 17, no. 3, pp. 325–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. W. Baynes and S. R. Thorpe, “Role of oxidative stress in diabetic complications: a new perspective on an old paradigm,” Diabetes, vol. 48, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Giugliano, A. Ceriello, and G. Paolisso, “Oxidative stress and diabetic vascular complications,” Diabetes Care, vol. 19, no. 3, pp. 257–267, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Yu, S.-S. Sheu, J. L. Robotham, and Y. Yoon, “Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species,” Cardiovascular Research, vol. 79, no. 2, pp. 341–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Boudina, H. Bugger, S. Sena et al., “Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart,” Circulation, vol. 119, no. 9, pp. 1272–1283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Teshima, N. Takahashi, S. Nishio et al., “Production of reactive oxygen species in the diabetic heart: roles of mitochondria and NADPH oxidase,” Circulation Journal, vol. 78, no. 2, pp. 300–306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Dallak, D. P. Mikhailidis, M. A. Haidara et al., “Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats,” Open Cardiovascular Medicine Journal, vol. 2, no. 1, pp. 70–78, 2008. View at Publisher · View at Google Scholar
  14. N. Takahashi, O. Kume, O. Wakisaka et al., “Novel strategy to prevent atrial fibrosis and fibrillation,” Circulation Journal, vol. 76, no. 10, pp. 2318–2326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Gryglewski, R. M. J. Palmer, and S. Moncada, “Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor,” Nature, vol. 320, no. 6061, pp. 454–456, 1986. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Mugge, J. H. Elwell, T. E. Peterson, and D. G. Harrison, “Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity,” The American Journal of Physiology—Cell Physiology, vol. 260, no. 2, part 1, pp. C219–C225, 1991. View at Google Scholar · View at Scopus
  17. B. Tesfamariam and R. A. Cohen, “Enhanced adrenergic neurotransmission in diabetic rabbit carotid artery,” Cardiovascular Research, vol. 29, no. 4, pp. 549–554, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. S. Katusic and P. M. Vanhoutte, “Superoxide anion is an endothelium-derived contracting factor,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 257, no. 1, part 2, pp. H33–H37, 1989. View at Google Scholar · View at Scopus
  19. P. H. Sugden and A. Clerk, “Cellular mechanisms of cardiac hypertrophy,” Journal of Molecular Medicine, vol. 76, no. 11, pp. 725–746, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Akki, M. Zhang, C. Murdoch, A. Brewer, and A. M. Shah, “NADPH oxidase signaling and cardiac myocyte function,” Journal of Molecular and Cellular Cardiology, vol. 47, no. 1, pp. 15–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. K. Griendling, D. Sorescu, and M. Ushio-Fukai, “NAD(P)H oxidase: role in cardiovascular biology and disease,” Circulation Research, vol. 86, no. 5, pp. 494–501, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. H. D. Wang, S. Xu, D. G. Johns et al., “Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice,” Circulation Research, vol. 88, no. 9, pp. 947–953, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-M. Li and A. M. Shah, “Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase,” Cardiovascular Research, vol. 52, no. 3, pp. 477–486, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Cave, D. Grieve, S. Johar, M. Zhang, and A. M. Shah, “NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 360, no. 1464, pp. 2327–2334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Patterson, J. Ruef, N. R. Madamanchi et al., “Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47phox may participate in forming this oxidase in vitro and in vivo,” Journal of Biological Chemistry, vol. 274, no. 28, pp. 19814–19822, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. K. P. Patel, W. G. Mayhan, K. R. Bidasee, and H. Zheng, “Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 300, no. 2, pp. R311–R320, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. M. Siragy, “AT(1) and AT(2) receptors in the kidney: role in disease and treatment,” American Journal of Kidney Diseases, vol. 36, no. 3, supplement 1, pp. S4–S9, 2000. View at Google Scholar
  28. J. R. Sowers, M. Epstein, and E. D. Frohlich, “Diabetes, hypertension, and cardiovascular disease—an update,” Hypertension, vol. 37, no. 4, pp. 1053–1059, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Koshkin, O. Lotan, and E. Pick, “The cytosolic component p47(phox) is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production,” The Journal of Biological Chemistry, vol. 271, no. 48, pp. 30326–30329, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. H. M. Siragy, A. Awad, P. Abadir, and R. Webb, “The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats,” Endocrinology, vol. 144, no. 6, pp. 2229–2233, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. M. E. Cifuentes, F. E. Rey, O. A. Carretero, and P. J. Pagano, “Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 279, no. 5, pp. H2234–H2240, 2000. View at Google Scholar
  33. D. Lang, S. I. Mosfer, A. Shakesby, F. Donaldson, and M. J. Lewis, “Coronary microvascular endothelial cell redox state in left ventricular hypertrophy: the role of angiotensin II,” Circulation Research, vol. 86, no. 4, pp. 463–469, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. J. K. Bendall, A. C. Cave, C. Heymes, N. Gall, and A. M. Shah, “Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice,” Circulation, vol. 105, no. 3, pp. 293–296, 2002. View at Publisher · View at Google Scholar
  35. K. K. Griendling, T. J. Murphy, and R. W. Alexander, “Molecular biology of the renin-angiotensin system,” Circulation, vol. 87, no. 6, pp. 1816–1828, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. K. K. Griendling, D. Sorescu, B. Lassègue, and M. Ushio-Fukai, “Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 10, pp. 2175–2183, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. K. K. Griendling and M. Ushio-Fukai, “Reactive oxygen species as mediators of angiotensin II signaling,” Regulatory Peptides, vol. 91, no. 1–3, pp. 21–27, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. P. J. Pagano, J. K. Clark, M. E. Cifuentes-Pagano, S. M. Clark, G. M. Callis, and M. T. Quinn, “Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 26, pp. 14483–14488, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Zhang, A. Schmeisser, C. D. Garlichs et al., “Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases,” Cardiovascular Research, vol. 44, no. 1, pp. 215–222, 1999. View at Publisher · View at Google Scholar
  40. M. Zhang, A. L. Kho, N. Anilkumar et al., “Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase,” Circulation, vol. 113, no. 9, pp. 1235–1243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Nishio, Y. Teshima, N. Takahashi et al., “Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 5, pp. 1103–1111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. R. Privratsky, L. E. Wold, J. R. Sowers, M. T. Quinn, and J. Ren, “AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase,” Hypertension, vol. 42, no. 2, pp. 206–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. U. Hink, H. Li, H. Mollnau et al., “Mechanisms underlying endothelial dysfunction in diabetes mellitus,” Circulation Research, vol. 88, no. 2, pp. E14–E22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. D. H. J. Thijssen, A. J. Maiorana, G. O'Driscoll, N. T. Cable, M. T. E. Hopman, and D. J. Green, “Impact of inactivity and exercise on the vasculature in humans,” European Journal of Applied Physiology, vol. 108, no. 5, pp. 845–875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Li, B. Culver, and J. Ren, “Benefit and risk of exercise on myocardial function in diabetes,” Pharmacological Research, vol. 48, no. 2, pp. 127–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Loimaala, H. V. Huikuri, T. Kööbi, M. Rinne, A. Nenonen, and I. Vuori, “Exercise training improves baroreflex sensitivity in type 2 diabetes,” Diabetes, vol. 52, no. 7, pp. 1837–1842, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Rousseau-Migneron, L. Turcotte, G. Tancrede, and A. Nadeau, “Transient increase in basal insulin levels in severely diabetic rats submitted to physical training,” Diabetes Research, vol. 9, no. 2, pp. 97–100, 1988. View at Google Scholar · View at Scopus
  48. M. E. Davis, H. Cai, L. McCann, T. Fukai, and D. G. Harrison, “Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1449–H1453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Kohno, S. Furukawa, H. Naito, K. Minamitani, D. Ohmori, and F. Yamakura, “Contribution of nitric oxide, angiotensin II and superoxide dismutase to exercise-induced attenuation of blood pressure elevation in spontaneously hypertensive rats,” Japanese Heart Journal, vol. 43, no. 1, pp. 25–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. R. W. Braith and D. G. Edwards, “Neurohormonal abnormalities in heart failure: impact of exercise training,” Congestive Heart Failure, vol. 9, no. 2, pp. 70–76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. T. L. Llewellyn, N. M. Sharma, H. Zheng, and K. P. Patel, “Effects of exercise training on SFO-mediated sympathoexcitation during chronic heart failure,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 1, pp. H121–H131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. C. E. Negrao, M. C. Irigoyen, E. D. Moreira, P. C. Brum, P. M. Freire, and E. M. Krieger, “Effect of exercise training on RSNA, baroreflex control, and blood pressure responsiveness,” The American Journal of Physiology, vol. 265, no. 2, part 2, pp. R365–R370, 1993. View at Google Scholar
  53. I. H. Zucker and R. U. Pliquett, “Novel mechanisms of sympatho-excitation in chronic heart failure,” Heart Failure Monitor, vol. 3, no. 1, pp. 2–7, 2002. View at Google Scholar · View at Scopus
  54. K. Husain, “Interaction of physical training and chronic nitroglycerin treatment on blood pressure, nitric oxide, and oxidants/antioxidants in the rat heart,” Pharmacological Research, vol. 48, no. 3, pp. 253–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Fukai, M. R. Siegfried, M. Ushio-Fukai, Y. Cheng, G. Kojda, and D. G. Harrison, “Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training,” Journal of Clinical Investigation, vol. 105, no. 11, pp. 1631–1639, 2000. View at Google Scholar · View at Scopus
  56. S. K. Powers, S. L. Lennon, J. Quindry, and J. L. Mehta, “Exercise and cardioprotection,” Current Opinion in Cardiology, vol. 17, no. 5, pp. 495–502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Fridovich, “The biology of oxygen radicals,” Science, vol. 201, no. 4359, pp. 875–880, 1978. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Balzan, D. R. Agius, and W. H. Bannister, “Cloned prokaryotic iron superoxide dismutase protects yeast cells against oxidative stress depending on mitochondrial location,” Biochemical and Biophysical Research Communications, vol. 256, no. 1, pp. 63–67, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. T. I. Musch and J. A. Terrell, “Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 262, no. 2, pp. H411–H419, 1992. View at Google Scholar · View at Scopus
  60. K. R. Bidasee, H. Zheng, C.-H. Shao, S. K. Parbhu, G. J. Rozanski, and K. P. Patel, “Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors,” Journal of Applied Physiology, vol. 105, no. 3, pp. 907–914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. P. A. Srere, “[1] Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)],” Methods in Enzymology, vol. 13, pp. 3–11, 1969. View at Publisher · View at Google Scholar · View at Scopus
  62. N. M. Sharma, H. Zheng, P. P. Mehta, Y.-F. Li, and K. P. Patel, “Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II,” Cardiovascular Research, vol. 92, no. 2, pp. 348–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. N. M. Sharma, H. Zheng, Y.-F. Li, and K. P. Patel, “Nitric oxide inhibits the expression of AT1 receptors in neurons,” American Journal of Physiology: Cell Physiology, vol. 302, no. 8, pp. C1162–C1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. P. M. Siu, D. A. Donley, R. W. Bryner, and S. E. Alway, “Citrate synthase expression and enzyme activity after endurance training in cardiac and skeletal muscles,” Journal of Applied Physiology, vol. 94, no. 2, pp. 555–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Levrand, C. Vannay-Bouchiche, B. Pesse et al., “Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo,” Free Radical Biology and Medicine, vol. 41, no. 6, pp. 886–895, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. V. J. Dzau, “Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis,” Hypertension, vol. 37, no. 4, pp. 1047–1052, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Fukui, N. Ishizaka, S. Rajagopalan et al., “p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats,” Circulation Research, vol. 80, no. 1, pp. 45–51, 1997. View at Publisher · View at Google Scholar
  68. J.-M. Li, A. M. Mullen, S. Yun et al., “Essential role of the NADPH oxidase subunit p47phox in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-α,” Circulation Research, vol. 90, no. 2, pp. 143–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. B. M. Babior, “NADPH oxidase: an update,” Blood, vol. 93, no. 5, pp. 1464–1476, 1999. View at Google Scholar · View at Scopus
  70. I. A. Williams and D. G. Allen, “The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 3, pp. H1969–H1977, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Shimizu, K. Umeda, N. Sugihara et al., “Collagen remodelling in myocardia of patients with diabetes,” Journal of Clinical Pathology, vol. 46, no. 1, pp. 32–36, 1993. View at Publisher · View at Google Scholar · View at Scopus
  72. P. J. Lijnen, J. F. van Pelt, and R. H. Fagard, “Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts,” Cardiovascular Therapeutics, vol. 30, no. 1, pp. e1–e8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Kasznicki and J. Drzewoski, “Heart failure in the diabetic population—pathophysiology, diagnosis and management,” Archives of Medical Science, vol. 10, no. 3, pp. 546–556, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. P. De Feo and P. Schwarz, “Is physical exercise a core therapeutical element for most patients with type 2 diabetes?” Diabetes Care, vol. 36, supplement 2, pp. S149–S154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, and J. Edwin Atwood, “Exercise capacity and mortality among men referred for exercise testing,” The New England Journal of Medicine, vol. 346, no. 11, pp. 793–801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. J. M. Goguen and L. A. Leiter, “Lipids and diabetes mellitus: a review of therapeutic options,” Current Medical Research and Opinion, vol. 18, supplement 1, pp. s58–s74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Zheng, N. M. Sharma, X. Liu, and K. P. Patel, “Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 303, no. 4, pp. R387–R394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. J. W. E. Rush, J. R. Turk, and M. H. Laughlin, “Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1378–H1387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Husain and S. R. Hazelrigg, “Oxidative injury due to chronic nitric oxide synthase inhibition in rat: effect of regular exercise on the heart,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1587, no. 1, pp. 75–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Shanmugam, M. A. Reddy, M. Guha, and R. Natarajan, “High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells,” Diabetes, vol. 52, no. 5, pp. 1256–1264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Rajagopalan, S. Kurz, T. Münzel et al., “Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone,” The Journal of Clinical Investigation, vol. 97, no. 8, pp. 1916–1923, 1996. View at Publisher · View at Google Scholar · View at Scopus
  82. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. W. Aldhahi and O. Hamdy, “Adipokines, inflammation, and the endothelium in diabetes,” Current Diabetes Reports, vol. 3, no. 4, pp. 293–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Straczkowski, I. Kowalska, S. Dzienis-Straczkowska et al., “Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance,” European Journal of Endocrinology, vol. 145, no. 3, pp. 273–280, 2001. View at Publisher · View at Google Scholar
  85. Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill, “Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 292, no. 4, pp. H1728–H1736, 2007. View at Publisher · View at Google Scholar · View at Scopus